Outcomes
Febrile illness
ADVERSE EVENTS, INDURATION, SECONDARY, TYPHOID FEVER, FEBRILE ILLNESS
The primary outcome is blood culture-confirmed typhoid fever.The secondary effectiveness outcomes are:• Febrile illness episodes lasting at least 3 days where healthcare is sought• Hospitalised culture-confirmed The safety outcomes, defined only in vaccine recipients, are:o Local induration at site of vaccinationo Reported fevero Headacheo Fatigue/tirednesso Anorexiao Abdominal paino Serious adverse eventso Solicited and unsolicited adverse eventsThe key process outcome is the proportion of participants age 1–29 in intervention clusters that are vaccinated, and will be reported in a CONSORT flow chart.